Essential oil of Melaleuca alternifolia for the treatment of oral candidiasis induced in an immunosuppressed mouse model

被引:23
作者
de Campos Rasteiro V.M. [1 ]
da Costa A.C.B.P. [1 ]
Araújo C.F. [1 ]
de Barros P.P. [1 ]
Rossoni R.D. [1 ]
Anbinder A.L. [1 ]
Jorge A.O.C. [1 ]
Junqueira J.C. [1 ]
机构
[1] Department of Biosciences and Oral Diagnosis, Institute of Science and Technology, UNESP - Univ Estadual Paulista, Francisco Jose Longo 777, Sao Dimas, Sao Jose dos Campos, Kragujevac, SP
来源
BMC Complementary and Alternative Medicine | / 14卷 / 1期
基金
巴西圣保罗研究基金会;
关键词
Candida albicans; Melaleuca alternifolia; Murine model; Oral candidiasis;
D O I
10.1186/1472-6882-14-489
中图分类号
学科分类号
摘要
Background: The search for alternative therapies for oral candidiasis is a necessity and the use of medicinal plants seems to be one of the promising solutions. The objective of this study was to evaluate the in vitro and in vivo effects of the essential oil of Melaleuca alternifolia on Candida albicans. Methods: The minimum inhibitory concentration (MIC) and minimum biofilm eradication concentration (MBEC) of M. alternifolia were determined by the broth microdilution assay. For the in vivo study, twelve immunosuppressed mice with buccal candidiasis received topical applications of M. alternifolia with MBEC. After treatment, yeasts were recovered from the mice and quantified (CFU/mL). Mice were killed for morphologic analysis of the tongue dorsum by optical and scanning electron microscopy. Data were analyzed using Student's t test or Mann-Whitney test. Results: The MIC of M. alternifolia was 0.195% and the MBEC was 12.5%. Treatment with M. alternifolia achieved a 5.33 log reduction in C. albicans and reduced the microscopic lesions of candidiasis. Conclusions: M. alternifolia oil at a 12.5% was effective to eradicate a C. albicans biofilm formed in vitro and to reduce yeasts of C. albicans in an immunosuppressed mouse model. © 2014 de Campos Rasteiro et al.
引用
收藏
相关论文
共 39 条
[1]  
Williams D.W., Kuriyama T., Silva S., Malic S., Lewis M.A., Candida biofilms and oral candidosis: treatment and prevention, Periodontol 2000, 55, pp. 250-265, (2011)
[2]  
Naglik J.R., Fidel P.L., Odds F.C., Animal models of mucosal Candida infection, FEMS Microbiol Lett, 283, pp. 129-139, (2008)
[3]  
Souza R.C., Junqueira J.C., Rossoni R.D., Pereira C.A., Munin E., Jorge A.O., Comparison of the photodynamic fungicidal efficacy of methylene blue, toluidine blue, malachite green and low-power laser irradiation alone against Candida albicans, Lasers Med Sci, 25, pp. 385-389, (2010)
[4]  
Junqueira J.C., Vilela S.F., Rossoni R.D., Barbosa J.O., Costa A.C., Rasteiro V.M., Suleiman J.M., Jorge A.O., Oral colonization by yeasts in HIV-positive patients in Brazil, Rev Inst Med Trop Sao Paulo, 54, pp. 17-24, (2012)
[5]  
Thompson G.R., Patel P.K., Kirkpatrick W.R., Westbrook S.D., Berg D., Erlandsen J., Redding S.W., Patterson T.F., Oropharyngeal candidiasis in the era of antiretroviral therapy, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, pp. 488-495, (2010)
[6]  
Schelenz S., Abdallah S., Gray G., Stubbings H., Gow I., Baker P., Hunter P.R., Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors, J Oral Pathol Med, 40, pp. 83-89, (2011)
[7]  
Seneviratne C.J., Jin L., Samaranayake L.P., Biofilm lifestyle of Candida: a mini review, Oral Dis, 14, pp. 582-590, (2008)
[8]  
Kuhn D.M., George T., Chandra J., Mukherjee P.K., Ghannoum M.A., Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins, Antimicrob Agents Chemother, 46, pp. 1773-1780, (2002)
[9]  
Dovigo L.N., Pavarina A.C., Mima E.G., Giampaolo E.T., Vergani C.E., Bagnato V.S., Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata, Mycoses, 54, pp. 123-130, (2011)
[10]  
Cateau E., Berjeaud J.M., Imbert C., Possible role of azole and echinocandin lock solutions in the control of Candida biofilms associated with silicone, Int J Antimicrob Agents, 37, pp. 380-384, (2011)